*WeRide was named among WICV 2026's "Top 10 Automotive AI Application Cases of 2026" for its Physical AI flywheel powered by GENESIS and WITT.

*Founder and CEO Dr. Tony Han shared WeRide's approach to applying L4 autonomous driving technology to L2 advanced driver-assistance systems, emphasizing intelligence density and safety.

*WeRide continues to expand real-world deployment across L2 to L4, with operations in more than 60 cities across 13 countries and an L4 fleet of approximately 3,600 vehicles.

BEIJING, Oct. 23, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, has been named among the "Top 10 Automotive AI Application Cases of 2026" at the 2026 World Intelligent Connected Vehicles Conference (WICV). The recognition highlights WeRide's innovative Physical AI flywheel powered by WeRide GENESIS and WeRide WITT, demonstrating how the company is translating cutting-edge AI technologies into large-scale commercial applications.

The selected case of WeRide's Physical AI flywheel, highlights the practical application of the collaborative application of cutting-edge AI technologies in autonomous driving development. At its core, the flywheel brings together WeRide GENESIS, WeRide's proprietary general-purpose simulation model, and WeRide WITT, WeRide's Physical AI Cognitive Foundation Model.

WeRide WITT extracts and validates physical facts from real-world road data, while WeRide GENESIS uses these insights to generate high-fidelity simulation scenarios that adhere to real-world physical laws, strengthening training in complex driving scenarios and long-tail situations. Together, the two models empower vehicle-side models, improve development efficiency and adaptability to complex scenarios, and support the deployment of autonomous driving technology across cities and vehicle platforms.

Focusing on the path to scaled production of autonomous driving, Dr. Tony Han, Founder and CEO of WeRide, delivered a keynote titled "The Critical Leap Toward Scaled Deployment of Autonomous Driving" at the conference's Key Technology Forum, sharing WeRide's experience in applying L4 expertise to L2 advanced driver-assistance systems (ADAS).

Dr. Han highlighted "intelligence density" as a key metric for evaluating ADAS solutions: how much intelligence each TOPS of computing power can deliver. The goal is to achieve a higher level of intelligent driving with limited computing resources. He also emphasized that investing in safety is essential to earning user trust and building long-term brand value. As the technology advances and its applications expand, safety must remain a priority at every stage, protecting not only passengers inside the vehicle but also every road user outside it.

WICV 2026 was held in Yizhuang, Beijing, from October 21 to 23, and was co-hosted by China's Ministry of Industry and Information Technology, Ministry of Transport, and the People's Government of Beijing Municipality. This year's conference was themed "Pooling Wisdom, Boundless Connectivity: Advancing Steadily Towards a New Era of Automated Driving". The conference has been held annually since 2018 and serves as a major industry event for intelligent connected vehicles, as well as an important platform for policy development and international cooperation.

WeRide's autonomous driving technologies were also showcased in real-world applications during the conference. During WICV 2026, WeRide deployed more than a dozen Robotaxis and Robobuses, providing autonomous ride experiences and shuttle services for attendees. The nearly 7-kilometer Robotaxi experience route started and ended at the main venue, while Robobuses provided shuttle services connecting conference venues and visitor destinations, including Yonghui Building, BAIC BluePark, Rocket Street, and Robot World.

Today, WeRide has commercialized its full-stack autonomous driving technologies spanning L2 to L4, with operations spanning more than 60 cities across 13 countries worldwide. Its L4 autonomous driving fleet comprises approximately 3,600 vehicles, supported by extensive operating experience across different cities and real-world use cases.

WeRide's autonomous passenger vehicles are already operating publicly in major global cities, including Guangzhou, Beijing, Abu Dhabi, Dubai, Singapore, Riyadh, and Zurich. Through global mobility platforms such as Uber and Grab, as well as local partners including SBB, ioki and TXAI, WeRide is integrating autonomous driving into more urban transportation networks and will soon launch services in additional markets including Spain and Denmark.

WeRide's L4 autonomous driving technology is also empowering mass-produced passenger vehicles through shared technology architecture. WRD 3.0, WeRide's one-stage end-to-end L2++ ADAS solution, has been deployed on models including the Chery Exeed Sterra, GAC AION N60, AION i60, and GAC Trumpchi Y7. To date, WRD 3.0 has secured production design wins across more than 30 vehicle models, bringing advanced driving technologies to a broader consumer base.

As the intelligent connected vehicle industry enters a new phase of development, WeRide will continue to advance Physical AI innovation and promote technological synergies across L2 to L4. Working with global industry partners, WeRide will expand the real-world application of its technologies at scale, translating technological progress into safer and more reliable mobility experiences.

About WeRide

WeRide is a global leader and a first mover in the autonomous driving industry, as well as the first publicly traded Robotaxi company. Our autonomous vehicles have been deployed in over 60 cities across 13 countries. We are also the first and only technology company whose products have received autonomous driving permits in nine markets: China, the UAE, Singapore, France, Switzerland, Saudi Arabia, Belgium, Spain, and the US. Empowered by the smart, versatile, cost-effective, and highly adaptable WeRide One platform, WeRide provides autonomous driving products and services from L2 to L4, addressing transportation needs in the mobility, logistics, and sanitation industries. WeRide was named to Fortune's Change the World lists in 2023, 2025, and 2026, and to the Fortune Future 50 list in 2025.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements.

Statements that are not historical facts, including statements about WeRide's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in WeRide's filings with the U.S. Securities and Exchange Commission and announcements on the website of the Hong Kong Stock Exchange.

All information provided in this press release is as of the date of this press release. WeRide does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Copyright  2026 GlobeNewswire, Inc.

HONG KONG SAR - Media OutReach Newswire - 23 October 2026 - Louis Vuitton unveils a new hoarding in Hong Kong following the iconic ones on the Champs-?lys?es in Paris in September 2023, in New York in November 2024, and in Shanghai in June 2025 .

Louis Vuitton unveils in October 2026 a spectacular hoarding inspired by one of the House's most emblematic themes: the Art of Travel. Throughout the refurbishment, the fa?ade is transformed into a grand train station, evoking the romance and golden age of travel. In celebration of the 130rh anniversary of the Monogram, this reimagined station will also be decorated with the House's distinctive Monogram motif.

Conceived as a tribute to the House's enduring fascination with travel, and as a nod to Hong Kong's comprehensive transportation history, the installation brings together heritage, imagination and architectural presence. In keeping with Louis Vuitton's commitment to more mindful creation, all materials used in the construction of the fa?ade will later be reused or recycled. Designed to capture the city's vibrant energy, this striking installation will be established as a new monument for all.

About Louis Vuitton

Since 1854, Louis Vuitton has brought unique designs to the world, combining innovation with style, always aiming the finest quality. Today, the House remains faithful to the spirit of its founder, Louis Vuitton, who invented a genuine "Art of Travel" through luggage, bags and accessories which were as creative as they were elegant and practical.

Since then, audacity has shaped the story of Louis Vuitton. Faithful to its heritage, Louis Vuitton has opened its doors to architects, artists and designers across the years, all the while developing disciplines such as ready-to-wear, shoes, accessories, watches, jewellery, beauty, and fragrance. These carefully created products are testament to Louis Vuitton's commitment to fine craftsmanship.

For further information: www.louisvuitton.com

The issuer is solely responsible for the content of this announcement.

Hashtags: #LouisVuitton

*Zymeworks to receive a $55 million upfront payment and a $40 million payment upon initiation of the Phase 1b trial, with potential for up to $718 million in additional development, commercial and sales-based milestones 

*Zymeworks also eligible to receive tiered high-single-digit to mid-teen royalties on global net sales protected by patents extending into 2040's

*Zymeworks will conduct the Phase 1a monotherapy clinical trial of ZW209 in collaboration with Roche 

*U.S. FDA IND clearance received with additional global regulatory applications planned to support the opening of clinical study sites outside the U.S.

*Transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976

*Conference call with Zymeworks management on October 27 at 8:30 am Eastern Time (ET)

VANCOUVER, British Columbia, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that it has entered into a global license and collaboration agreement with Roche for the research, development and commercialization of ZW209, a T cell engager targeting DLL3.

Under the agreement, Zymeworks is eligible to receive an upfront payment of $55 million, a $40 million payment upon initiation of the Phase 1b trial, and additional development, commercial and sales-based milestone payments of up to $718 million, and tiered high single digit to mid-teen royalties on future net sales of any approved medicines resulting from the collaboration.

The transaction remains subject to the expiration or termination of the applicable waiting period under the HSR Act, as well as the satisfaction of other customary closing conditions and, where applicable, receipt of other required regulatory approvals.

Zymeworks will conduct the Phase 1a monotherapy trial of ZW209 in collaboration with Roche, bringing together Zymeworks' expertise in multispecific antibody therapeutics with Roche's global capabilities in the research, development, manufacturing and commercialization of cancer medicines. Roche will fund the Phase 1a trial and be responsible for subsequent global development and commercialization of ZW209. Under the agreement, Roche will have the exclusive right to develop and commercialize ZW209 globally.

"This collaboration allows us to continue advancing ZW209 through its initial clinical development while leveraging Roche's complementary capabilities to accelerate and expand its development across indications and treatment settings. The agreement also reflects our broader strategy of generating innovative programs through our R&D engine and partnering selected assets in ways that share development risk while preserving meaningful participation in their future success," said Adam Schayowitz, Ph.D., MBA, Executive Vice President and Head of R&D at Zymeworks.

"ZW209 represents an innovative approach that complements our ongoing efforts to develop new treatment options for people living with lung cancer," said Boris L. Zaitra, Head of Corporate Business Development at Roche. "We look forward to collaborating with Zymeworks to fully explore its therapeutic potential."

The collaboration is part of Zymeworks' broader strategic initiative to advance differentiated therapeutic candidates internally while selectively partnering programs where complementary capabilities can accelerate development, expand potential and share development risk. Beyond ZW209, Zymeworks has an extensive portfolio of research programs of multispecific T cell engagers against targets in solid tumors, hematological tumors, and AIID.

Investor Call Details

Zymeworks invites investors and the general public to view and listen to a live webcast of its conference call with investment analysts at 8:30 am ET on October 27, 2026.

Dial-in details and webcast link are available on Zymeworks' website at https://ir.zymeworks.com/events-and-presentations. A webcast replay of the call will be available on the Zymeworks website within 24 hours following the conclusion of the live call and will be archived for a limited period.

About ZW209

ZW209 is a novel trispecific T cell engager (TriTCE), developed to target DLL3-expressing tumor cells while simultaneously engaging T cells via binding to CD3 and CD28. Optimally configured using Zymeworks' novel TriTCE Co-Stim and clinically validated Azymetric and EFECT platforms, ZW209 is designed to enhance patient anti-tumor T cell responses through CD28 co-stimulation.

By leveraging obligate cis-T cell binding and conditional CD28 engagement, ZW209 is structured to prevent unintended T cell activation, while enabling tumor-targeted cytotoxicity. Preclinically ZW209 has demonstrated differentiated long-term cytotoxicity in vitro, with enhanced T cell proliferation and survival, offering significant potential to increase durability of responses in DLL3-expressing cancers.

With U.S. Food and Drug Administration Investigational New Drug clearance received, a Phase 1, open-label, multicenter, global study investigating ZW209 has been initiated to evaluate safety, tolerability, pharmacokinetics, and preliminary antitumor activity. The study will enroll adult participants with select advanced solid tumors, including small cell lung cancer and other DLL3 expressing neuroendocrine tumors.

About Zymeworks Inc.

Zymeworks is a global biotechnology company building a diversified portfolio of healthcare assets designed to generate durable cash flows while advancing innovative medicines for difficult-to-treat diseases. The Company's asset and royalty aggregation strategy combines a growing portfolio of commercial and near-commercial assets, including YUPELRI? (revefenacin), with a differentiated internal research and development engine. Zymeworks' portfolio also includes Ziihera? (zanidatamab-hrii), a HER2-targeted bispecific antibody discovered and developed by Zymeworks and commercialized through global partnerships with Jazz Pharmaceuticals and BeOne Medicines, and pasritamig, a clinical-stage multispecific antibody developed by Johnson & Johnson using Zymeworks' proprietary antibody engineering technologies.

Zymeworks is advancing a diverse pipeline of novel biotherapeutics, leveraging its proprietary Azymetric? platform and expertise in antibody-drug conjugates, multispecific antibodies and other next-generation antibody technologies. These capabilities, together with Zymeworks' integrated drug development expertise, enable the Company to develop differentiated therapeutics and create value through both internal innovation and strategic partnerships.

For more information about Zymeworks, its portfolio and pipeline, visit www.zymeworks.com and follow @ZymeworksInc on X.

Cautionary Note Regarding Forward-Looking Statements

This press release includes "forward-looking statements" or information within the meaning of the applicable securities legislation, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Forward-looking statements in this press release include, but are not limited to, statements that relate to Zymeworks' expectations regarding implementation of its long-term strategy to maximize value creation; Zymeworks' and its partners' clinical development of product candidates; potential safety profile and therapeutic effects of product candidates; the commercial potential of technology platforms and product candidates; the anticipated benefits of its collaboration agreements; and other information that is not historical information.

When used herein, words such as "plan", "believe", "expect", "may", "continue", "anticipate", "potential", "will", "on track", "progress", "preserve", "intend", "could", and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.

All forward-looking statements are based upon Zymeworks' current expectations and various assumptions. Zymeworks believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various factors, including, without limitation: any of Zymeworks' or its partners' product candidates may fail in development, may not receive required regulatory approvals, or may be delayed to a point where they are not commercially viable; uncertainties regarding the commercial success of YUPELRI and TRELEGY; Zymeworks may not achieve milestones or receive additional payments or royalties under its collaborations; regulatory agencies may impose additional requirements or delay the initiation of clinical trials; the impact of new or changing laws and regulations; market conditions, including the impact of tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal agencies such as the FDA, staff layoffs, budget cuts to agency programs and research, and changes in drug pricing controls; the impact of pandemics and other health crises on Zymeworks' business, research and clinical development plans and timelines and results of operations, including impact on its clinical trial sites, collaborators, and contractors who act for or on Zymeworks' behalf; zanidatamab may not be successfully commercialized; Zymeworks' business strategy related to anticipated and potential future milestones and royalty streams and existing and potential new partnerships may not be successfully implemented; Zymeworks' evolution of its business strategy may not deliver meaningful stockholder returns; Zymeworks may be unsuccessful in actively managing and/or aggregating revenue-generating assets alongside its active R&D operations; ongoing and future clinical trials may not demonstrate safety and efficacy of any of Zymeworks' or its collaborators' product candidates; data providing early validation of our antibody drug conjugate platform and next generation pipeline programs may not be replicated in future studies; Zymeworks' assumptions and estimates regarding its financial condition, future financial performance and estimated cash runway may be incorrect; inability to maintain or enter into new partnerships or strategic collaborations; the inability of Zymeworks to identify and consummate a strategic acquisition; and the factors described under "Risk Factors" in Zymeworks' quarterly and annual reports filed with the Securities and Exchange Commission (copies of which may be obtained at www.sec.gov and www.sedarplus.ca).

Although Zymeworks believes that such forward-looking statements are reasonable, there can be no assurance they will prove to be correct. Investors should not place undue reliance on forward-looking statements. The above assumptions, risks and uncertainties are not exhaustive. Forward-looking statements are made as of the date hereof and, except as may be required by law, Zymeworks undertakes no obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances, or to reflect the occurrences of unanticipated events.

Copyright 2026 GlobeNewswire, Inc.

Membangun fondasi operasional bagi kecerdasan generasi berikutnya di lingkungan hotel

SINGAPURA, Oct. 23, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (Nasdaq: YFOR) ("YYForce" atau "Perusahaan"), penyedia layanan pengelolaan tenaga kerja dan pengelolaan fasilitas terpadu yang didukung AI, hari ini memaparkan visinya untuk mengembangkan platform terpadu yang menghubungkan keahlian manusia, kecerdasan buatan, robotika, dan sistem bangunan pintar.

Ambisi jangka panjang Perusahaan adalah membangun infrastruktur operasional yang dapat mendukung penerapan kecerdasan super di masa depan dalam sektor perhotelan dan lingkungan binaan, jika kemampuan tersebut telah tersedia.

Platform yang direncanakan ini bertujuan membantu operator hotel mengoordinasikan tenaga kerja, penyediaan layanan, tugas-tugas robot, dan kinerja bangunan melalui lapisan operasional bersama. YYForce bertujuan menghubungkan informasi dari sistem hotel dan sensor IoT dengan alur kerja yang memungkinkan manusia, robot, dan peralatan yang terhubung untuk merespons kebutuhan operasional.

Membangun Infrastruktur Operasional untuk Kecerdasan Super di Masa Depan

Pendekatan yang diusulkan YYForce bertujuan mengintegrasikan penilaian manusia dan keahlian dalam pelayanan, perkiraan dan perencanaan yang dibantu AI, sistem robotika dan humanoid untuk tugas-tugas fisik yang sesuai, serta pemantauan dan pengendalian yang didukung IoT. Prioritas pengembangan mencakup integrasi data, koordinasi tugas, verifikasi hasil, dan pengawasan manusia.

Sebagai contoh, seperti yang dibayangkan, alur kerja yang terhubung berpotensi menggunakan informasi check-out untuk menjadwalkan pembersihan kamar dan mengalokasikan dukungan robot yang sesuai. Selain itu, sistem juga dapat menyesuaikan pencahayaan dan pendinginan kamar dalam batas kenyamanan yang telah disetujui. Data penyelesaian tugas dan umpan balik sensor berpotensi membantu operator memverifikasi kesiapan kamar dan menilai kinerja operasional.

"Ambisi kami adalah memberikan cara praktis bagi AI yang semakin canggih untuk memahami dan mendukung operasional hotel yang sesungguhnya," ujar Mike Fu, Chief Executive Officer YYForce. "Dengan menghubungkan manusia, sistem robotika, dan sistem bangunan, kami ingin mengubah informasi operasional menjadi tindakan yang terkoordinasi dan hasil yang terukur. Seiring waktu, kami yakin infrastruktur ini dapat mendukung penerapan kecerdasan super di masa depan, dengan tetap memastikan adanya kejelasan dalam pembagian wewenang dan tanggung jawab operasional."

Menghubungkan Peningkatan Bangunan Pintar dengan Visi Kecerdasan Super

Sebagai bagian dari arah pengembangan ini, YYForce berencana mengintegrasikan solusi peningkatan kualitas hotel yang mencakup sensor okupansi dan lingkungan, pengendalian pencahayaan, pengaturan suhu, pemantauan peralatan, serta alur kerja pemeliharaan. Tujuannya adalah membantu pengelola properti meningkatkan kenyamanan tamu, mengurangi konsumsi energi yang tidak perlu, serta merespons masalah pada peralatan lebih awal.

Perusahaan berencana mendukung upaya hotel menuju operasional dengan emisi karbon yang lebih rendah melalui pemantauan energi, pengoptimalan operasional, dan pengukuran kinerja. Peningkatan kualitas sistem bangunan pintar saja tidak cukup menjadikan properti berstatus emisi karbon nol bersih. Setiap klaim emisi karbon nol bersih di masa depan harus didukung oleh cakupan emisi yang ditetapkan secara jelas, kinerja yang terverifikasi, serta langkah-langkah yang tepat untuk menangani pasokan energi dan emisi yang tersisa.

Jalur Pengembangan yang Terukur Menuju Penerapan Kecerdasan Super di Masa Depan

Pendekatan pengembangan yang diusulkan YYForce akan dimulai dengan alur kerja yang jelas di sektor perhotelan, dilanjutkan dengan penetapan tolok ukur kinerja dan evaluasi hasil sebelum memperluas otomatisasi. Aspek yang direncanakan untuk dievaluasi meliputi penyelesaian layanan, kesiapan kamar, produktivitas tenaga kerja, penggunaan energi, dan keandalan. Peningkatan akan diuji sebelum diterapkan secara lebih luas, dengan mekanisme eskalasi kepada manusia serta batasan operasional yang disesuaikan dengan setiap penerapan.

Visi kecerdasan super merupakan ambisi strategis jangka panjang. YYForce tidak mengumumkan bahwa perusahaan tersebut telah mengembangkan kecerdasan umum buatan atau kecerdasan super buatan. Fokus jangka pendek perusahaan adalah membangun platform operasional yang terintegrasi. Sementara itu, penggunaan sistem kecerdasan super di masa depan akan bergantung pada kemajuan kemampuan dasar AI serta keberhasilan validasi teknis dan operasional.

Tentang YYForce

YYForce Inc. (Nasdaq: YFOR) adalah penyedia layanan pengelolaan tenaga kerja dan pengelolaan fasilitas terpadu (IFM) yang didukung AI, yang berkantor pusat di Singapura serta beroperasi di Asia dan wilayah lainnya. Melalui bisnis IFM dan teknologi tenaga kerjanya, YYForce menyediakan solusi pengerahan dan pengelolaan tenaga kerja serta layanan fasilitas di berbagai industri jasa.

Platform tenaga kerja Perusahaan, YY Circle, mendukung pengerahan dan pengelolaan tenaga kerja di berbagai sektor, termasuk perhotelan, makanan dan minuman, ritel, serta industri jasa lainnya. Dalam operasional IFM-nya, YYForce memadukan layanan fasilitas garis depan dengan solusi teknologi yang dirancang untuk meningkatkan produktivitas tenaga kerja dan efisiensi operasional.

Strategi jangka panjang YYForce berfokus pada pembangunan ekosistem tenaga kerja masa depan terintegrasi. Dalam ekosistem ini, kolaborasi antara tenaga kerja manusia, perangkat lunak cerdas, otomatisasi, dan robotika akan terus ditingkatkan untuk memberikan layanan dengan lebih efisien.

Pernyataan Berwawasan ke Depan

Siaran pers ini berisi pernyataan berwawasan ke depan dalam artian yang terkandung di Pasal 27A Securities Act tahun 1933, sebagaimana diubah, dan Pasal 21E Securities Exchange Act tahun 1934, sebagaimana diubah. Perusahaan mendasarkan pernyataan berwawasan ke depan tersebut pada ekspektasi dan proyeksinya mengenai peristiwa di masa depan, yang disusun Perusahaan berdasarkan informasi yang tersedia saat ini bagi Perusahaan. Anda dapat mengidentifikasi pernyataan berwawasan ke depan melalui pernyataan yang tidak bersifat historis, terutama yang menggunakan terminologi seperti "dapat," "seharusnya," "mengharapkan," "mengantisipasi," "mempertimbangkan," "memperkirakan," "meyakini," "merencanakan," "diproyeksikan," "memprediksi," "berpotensi," atau "berharap," atau bentuk negatif dari istilah-istilah ini maupun istilah serupa lainnya. Pernyataan mengenai rencana pengembangan, fitur, jadwal, dan komersialisasi platform Workforce OS serta aplikasi robotika terkait merupakan pernyataan berwawasan ke depan.

Pernyataan berwawasan ke depan mengandung risiko dan ketidakpastian yang melekat sehingga peristiwa di masa depan yang dibahas dalam siaran pers ini mungkin tidak terjadi. Peristiwa dan hasil aktual dapat berbeda secara signifikan serta bergantung pada risiko, ketidakpastian, dan asumsi mengenai Perusahaan dan sejumlah faktor lainnya. Faktor-faktor ini termasuk, tetapi tidak terbatas pada, sasaran dan strategi Perusahaan; pengembangan bisnis, kondisi keuangan, dan hasil operasional Perusahaan di masa mendatang, termasuk peluncuran produk dan layanan baru, perkiraan perubahan pendapatan, biaya, dan pengeluaran Perusahaan, perkiraan pertumbuhan pelanggan, serta permintaan dan penerimaan pasar terhadap produk dan layanan Perusahaan; serta kondisi industri, pasar, dan regulasi, termasuk persaingan, kebijakan dan peraturan pemerintah yang memengaruhi industri Perusahaan, serta faktor lainnya yang dapat memengaruhi kondisi keuangan, likuiditas, dan hasil operasional Perusahaan.

Untuk pembahasan lebih detail mengenai faktor risiko, rujuk dokumen yang diserahkan Perusahaan kepada Komisi Sekuritas dan Bursa, termasuk bagian "Faktor Risiko" dalam laporan tahunan terbaru Perusahaan pada Formulir 20-F, sebagaimana diubah. Pembaca juga harus mempertimbangkan risiko yang dijelaskan dalam pengajuan Perusahaan kepada Komisi Sekuritas dan Bursa AS. YYForce tidak berkewajiban untuk memperbarui pernyataan ini kecuali sebagaimana diwajibkan oleh hukum yang berlaku.

Copyright 2026 GlobeNewswire, Inc.

Clients of EBC Financial Group can now trade from the same app they use to open, fund, and manage their accounts

LONDON, Oct. 23, 2026 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) has expanded live trading in the EBC App, bringing account management, funding tools, and trade execution together on one mobile platform.

First introduced in stages on 14 September 2026, the trading feature has since been extended to additional markets, with a further rollout recorded on 21 October. Access remains subject to each client's location, account eligibility, and the EBC entity providing the service.

"Our mission is to help our clients trade better by making our platform accessible any time, any anywhere. The EBC App now allows them to monitor their accounts, follow the status of their orders, and manage their exposure without switching between several platforms. Bringing these functions together should make day-to-day account management more straightforward, while keeping trading risks and responsibilities clear," said Andria Phiniefs, Marketing Director, EBC Financial Group.

What Clients Can Do in the App

Clients can view real-time quotes and trade contracts for difference (CFDs), which let them take a position on price moves without owning the underlying asset, across more than 300 forex pairs, commodities, indices, stocks, and exchange-traded funds. They can place market orders, which fill at the current price, or pending orders, which execute only if the price reaches a level they choose. They can also set take-profit and stop-loss levels, which close a position automatically at a chosen gain or loss, cancel orders, and close several positions with a single tap.

These tools let traders set their limits before a trade moves, which matters because CFDs are traded on margin. Leverage magnifies gains and losses alike, and losses can exceed deposits. A stop-loss is not a guarantee either. In fast-moving markets, prices can jump past a chosen level, a move known as a gap, and the order may then fill at a worse price. The order tools, set out when EBC launched the app in July, are there to give traders clearer control over their exposure, not to remove that risk.

One App from Account Opening to Trade

EBC announced the EBC App on 7 July 2026 as an account management platform. Clients could already open an account and complete identity verification in the app, make deposits and withdrawals, and reach 24/7 multilingual support. They could also switch between accounts, with funds, positions, and trading activity synchronised in real time. With live trading added, the same app now covers the final step of placing a trade.

What Happens After the Tap

Through the group's Smart Order Routing Engine, more than 87.6% of EBC orders are filled at a better price than requested. In other words, those orders were filled at a price more favourable to the client than the one quoted when they were placed. EBC's trading environment provides an average execution speed of 20ms, capacity to process 1,000 orders per second, and 98.75% system stability, supported by Tier 4 private leased-line servers across five global financial hubs and 30 data centres worldwide.

Pricing draws on more than 50 bank and non-bank liquidity providers, including J.P. Morgan, UBS, Barclays, and Goldman Sachs. EBC offers raw ECN spreads from 0.0 pips, where the spread is the gap between the buy and sell price, and five levels of market depth, which show the prices and volumes available beyond the best quote.

EBC App Availability

The EBC App, provided by EBC Financial Group (SVG) LLC, is available for iOS and Android through the official download page at https://www.ebc.com/mobile. Trading functionality, instruments, and account services are subject to applicable local requirements and client eligibility.

Forex and CFD trading on margin involve significant risk, including the possibility of rapid losses. Stop-loss instructions may help manage exposure, but they cannot guarantee execution at a particular price. The protections available to clients, including any limits on losses, depend on their contracting entity, account classification, and applicable rules.

Disclaimer: This material is for information only and does not constitute a recommendation or advice from EBC Financial Group and all its entities ("EBC"). Trading Forex and Contracts for Difference (CFDs) on margin carries a high level of risk and may not be suitable for all investors. Losses can exceed your deposits. Before trading, you should carefully consider your trading objectives, level of experience, and risk appetite, and consult an independent financial advisor if necessary. Statistics or past investment performance are not a guarantee of future performance. EBC is not liable for any damages arising from reliance on this information.

About EBC Financial Group

Founded in London and named World Finance's "Best Global Broker" for four years running, EBC Financial Group operates entities regulated by the FCA, ASIC, CIMA, and FSCA, serving over 8 million registered users across more than 100 countries and regions. An Official Partner of FC Barcelona, EBC also champions financial education with the Department of Economics at the University of Oxford, the UN Foundation's United to Beat Malaria programme, and a range of children's charities worldwide through its charity, EBC Group Foundation.

Copyright 2026 GlobeNewswire, Inc.

Ascom completes share capital reduction following share buyback program

Baar, Switzerland, 23 October 2026

Ascom Holding AG has completed the share capital reduction following the share buyback program concluded on 19 June 2026.

The 3,000,000 registered shares repurchased under the share buyback program for the purpose of a subsequent capital reduction have been cancelled, reducing Ascom's share capital accordingly.

Following the cancellation, Ascom's share capital amounts to CHF 16,500,000, divided into 33,000,000 registered shares with a nominal value of CHF 0.50 each.

Further information is available in Ascom's 19 June 2026 announcement on the completion of the share buyback program. Link

Attachment

Ascom_Mediarelease_ShareCapitalReduction

Copyright ? 2026 GlobeNewswire, Inc.

MANILA, Philippines, Oct. 23, 2026 (GLOBE NEWSWIRE) -- The Asian Productivity Organization (APO) convened its 67th Workshop Meeting of Heads of National Productivity Organizations (WSM) in Manila from 20 to 22 October 2026.

The meeting brought together national productivity organization (NPO) Heads and delegates from APO member economies to review progress in implementing Strategic Partnership Program (SPP) Plan activities, exchange experiences, and consider proposals and updates on key APO programs and initiatives under the APO Vision 2030.

The meeting marked a further step in moving the SPP from planning to implementation. NPO Heads shared updates on their respective SPP Plan activities, including progress, approaches, challenges, lessons learned, and opportunities for closer cooperation. The WSM also reviewed SPP Plan activities in 2026 and planned activities for 2027.

The inaugural session featured opening remarks by the APO Director for the Philippines and Secretary of the Department of Economy, Planning, and Development, Dr. Arsenio M. Balisacan; a statement by the APO Secretary-General, Dr. Indra Pradana Singawinata; and an inaugural address by guest of honor Kim Robert C. de Leon, Secretary of the Department of Budget and Management of the Philippines.

In his opening remarks, Dr. Balisacan emphasized the importance of regional cooperation and aligning APO initiatives with national priorities: "APO Vision 2030 sets our shared direction, while the Strategic Partnership Program, or SPP, provides a framework for initiatives aligned with national priorities."

Dr. Indra highlighted SPP implementation as a key focus of the WSM, emphasizing its role in strengthening member ownership, making APO support more member focused, and improving the delivery of measurable results.

Manila holds an important place in the APO's history: It hosted the Second Asian Round Table Productivity Conference in 1960, where the draft convention that became the APO charter was adopted. On 14 April 1961, the Convention establishing the APO was signed in Manila by eight founding members, including the Philippines.

Reflecting on this history, Dr. Indra said, "As the APO celebrates its 65th anniversary this year, it is fitting that we return to Manila not only to reflect on our beginnings but also to consider how the organization should continue to evolve under the APO Vision 2030."

Secretary de Leon placed the discussions in the broader context of the impact of productivity on people's lives. Emphasizing that productivity should ultimately translate into tangible improvements for citizens, he stated, "At the end of the day, the greatest achievement of productivity is prosperity that people can actually feel."

The inaugural session also featured the launch of the APO Guidebook on Green Productivity, the presentation of an APO Accreditation Body certificate recognizing the reaccreditation of the Mongolian Productivity Organization Certification Body for a second term through 5 December 2030, and the signing of a memorandum of understanding between the Department of Budget and Management and the Development Academy of the Philippines for the Public Financial Management Microcredentialing Program for Budget Officers and Analysts.

Other discussions covered the 2025 Annual Project Review, the performance of APO centers of excellence, the APO Liaison Officers' Meeting, and APO Genuine AI Action activities.

On the second day, delegates considered proposals and reports from the APO Secretariat on revisions to the APO Award Program, the proposed establishment of an APO training center, and updates to the APO Accreditation and Certification Program, as part of continuing efforts to strengthen institutional mechanisms under Vision 2030.

Discussions throughout the WSM reflected the priorities of Vision 2030, emphasizing member-driven programming, measurable results, and APO support aligned with member economy priorities.

About the APO

The APO is a regional intergovernmental organization dedicated to improving productivity in the Asia-Pacific region through mutual cooperation. Established in 1961, the APO supports its member economies through policy advisory services, capacity building, and knowledge sharing to promote sustainable socioeconomic development.

Copyright 2026 GlobeNewswire, Inc.

SEOUL, Oct. 23, 2026 (GLOBE NEWSWIRE) -- SECO, merek suku cadang otomotif milik SEOJIN AUTOMOTIVE, menyoroti pengalaman selama enam dekade serta komitmen berkelanjutannya terhadap kualitas, daya tahan, keselamatan, dan nilai yang kompetitif dalam rangka merayakan hari jadinya yang ke-60 pada tahun 2026.

Didirikan pada tahun 1966, SECO telah membangun reputasinya tidak hanya melalui pasokan komponen OEM kepada produsen mobil global, tetapi juga melalui penyediaan suku cadang aftermarket yang dirancang untuk memenuhi kebutuhan distributor, bengkel, dan berbagai pengguna akhir.

Saat ini, SECO Aftermarket menawarkan beragam suku cadang pengganti yang mencakup sistem utama kendaraan, termasuk kopling, kampas rem, komponen suspensi, peredam kejut, sambungan kecepatan konstan (CV Joint), bantalan (bearing), komponen sistem pengapian, serta berbagai komponen penting lainnya.

"Selama 60 tahun, kami telah berupaya menyediakan produk yang dapat diandalkan oleh pelanggan dan mitra bisnis kami. Fokus kami tetap jelas: kualitas produk yang konsisten, kinerja yang andal, dan nilai praktis bagi pasar suku cadang aftermarket otomotif global," tambah SECO.

SECO Aftermarket menerapkan pengendalian kualitas berdasarkan standar OE (Original Equipment) di seluruh rangkaian produknya. Pendekatan ini mendukung konsistensi proses produksi dan pemeriksaan, sekaligus membantu pelanggan memilih suku cadang otomotif aftermarket dengan percaya diri. Dengan menggabungkan cakupan produk yang luas serta fokus pada daya tahan dan keselamatan, SECO bertujuan untuk mendukung pemeliharaan kendaraan yang efisien dan kepuasan pelanggan dalam jangka panjang.

Portofolio produk aftermarket perusahaan dirancang untuk memenuhi kebutuhan yang terus berkembang dari jaringan layanan perawatan dan distribusi otomotif. Produk-produknya dikembangkan untuk memberikan kinerja yang andal dalam kondisi berkendara sehari-hari, sekaligus menawarkan alternatif yang kompetitif bagi perusahaan yang mencari suku cadang pengganti berkualitas dan proses pengadaan yang efisien.

"Pencapaian 60 tahun SECO bukan hanya merupakan perayaan atas sejarah kami, tetapi juga sebuah janji untuk masa depan," tambah SECO. "Kami akan terus membangun kepercayaan melalui kualitas, memperluas rangkaian produk kami, dan menciptakan nilai bagi para mitra di seluruh pasar suku cadang aftermarket otomotif."

SECO Aftermarket mengundang distributor suku cadang otomotif, pembeli suku cadang, bengkel, dan para profesional industri untuk mengetahui lebih lanjut mengenai rangkaian produk serta peluang kemitraan yang ditawarkan.

Untuk informasi lebih lanjut mengenai SECO Aftermarket, silakan lihat informasi berikut.

Situs Web Resmi: https://secoautomotive.com

LinkedIn: https://www.linkedin.com/company/seojinautomotive

Email: amt18200@secoautomotive.com

Katalog Online: www.secoautomotive.co.kr

Copyright 2026 GlobeNewswire, Inc.

Top bartenders from 49 countries competed in Scotland for the coveted title

EDINBURGH, United Kingdom, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Zana Mohlmann from Singapore has been crowned Diageo World Class Global Bartender of the Year 2026 at the world's biggest cocktail competition, taking top place among finalists from six continents.

M?hlmann of East47 at Conrad Singapore Orchard combined technical mastery and creative flair with the warm, intuitive hospitality that defines a truly world class bartender.

Originally from the Netherlands, she found bartending on a gap year in Asia and trained in Amsterdam's bars. She then joined the opening team of Ryan Chetiyawardana's Super Lyan, rising to Head Bartender. She spent months refining every serve in preparation for the Global Finals, dedication that paid off last night in Edinburgh.

Alongside the title, Zana will represent Diageo and its brands in a year-long opportunity to showcase her bartending skills around the world and, for the first time, this year's Global Bartender of the Year will partner with Diageo to create a ready-to-drink cocktail that will launch in multiple markets next year. The title also includes an all-expenses trip to the 2027 World Class Global Final.

A 16-strong international judging panel of well-known leading figures from the global bar industry, including Ago Perrone of London's Connaught Bar, Monica Berg of Tayer + Elementary, and Lorenzo Antinori of Hong Kong's Bar Leone (recently named The World's Best Bar at The 50 Best Bars 2026, for the second consecutive year) judged competitors across a series of live brand challenges (challenges listed in notes to editors, below).

Speaking on behalf of the judging panel, Ago Perrone said:

"My fellow judges and I have been impressed by the dedication and the efforts that have gone into each creation this year. It's always so inspiring to watch the next generation at work, even more so Zana. Zana won us over thanks to the imagination, commitment and real heart she put into the challenges showing the warmth of a true host. And that's what really makes a World Class bartender."

The World Class programme showcases Diageo's commitment to a vibrant hospitality sector, the on-trade and its customers, while creating a space to share insights on the latest drinking trends. Since 2009, the programme has celebrated and nurtured the careers of over 500,000 bartenders.

Kevin Delaney, Global Head of World Class, said:

"World Class is the ultimate toast to the beating heart of the hospitality industry: rockstar bartenders pushing the boundaries of their creativity and skill through competition - hosting tirelessly, serving responsibly and setting the trends we'll all experience in the future. It's a program dedicated to the trade - because when bartenders flourish, the experience is enhanced for everyone. We are delighted to welcome Zana into the Diageo World Class Hall of Fame."

This year, the Global Finals were marked with Scotland Served, a World Class Festival transforming more than 400 venues across the country into destinations for exploration into Scotch Whisky, showcasing a new generation of Scotch cocktails from Johnnie Walker and The Singleton.

Celebrating both the World Class win and her 29th birthday on the same night, Zana Mohlmann World Class Global Bartender of the Year 2026, said:

"It's unbelievable. I don't think I know how to feel yet. I'd let myself imagine this moment a little, but I was almost scared to, and there were moments I didn't think I would win. I've never been so happy, or so surprised."

With the Global Finals on Scottish soil, the judging panel also included Scottish talent, including Iain McPherson of Edinburgh's award-winning Panda & Sons; Andy Gemmell, owner of The Gate pub in Glasgow; and Kaitlin Wilkes, co-founder of The Ada Coleman Project.

The bartender challenges included:

'Community Spirit', Ketel One Vodka high-stakes relay of precision and speed

'The Slow Train', an intimate cocktail and food pairing featuring The Singleton Whisky aboard a private train to the brand's Glen Ord Distillery

'Under Pressure', reimagining Don Julio Tequila as a ready-to-drink, carbonated serve with original label artwork

'Iconology', a head-turning Tanqueray No. TEN Gin cocktail built to command a room

'Fast Forward', a three-drink Johnnie Walker Black Label mixtape flight, each cocktail paired with a music track from [HIS/HER/THEIR] bartending journey.

Assets available: Images of winner, spokesperson for interviews.

WINNER'S BIO

Zana M?hlmann is the Beverage Manager of Manhattan and East47 at Conrad Singapore Orchard. At Manhattan, she builds upon the fvenue's celebrated legacy, honouring the Golden Age of cocktails while evolving its story through innovative menu concepts such as Seasons of Manhattan. At East47, she champions a more experimental approach, pushing creative boundaries while maintaining a relentless focus on flavour and guest experience.

Previously Manhattan's Head Bartender, Zana played a key role in shaping the bar's creative identity while fostering a culture of collaboration, mentorship, and inclusivity. Today, she oversees the beverage vision for both venues, balancing heritage with innovation and strengthening Manhattan's global reputation while establishing East47 as an emerging destination on the international cocktail scene.

Originally from the Netherlands, Zana discovered bartending during a gap year travelling through Asia. She refined her craft in acclaimed Amsterdam bars before joining the opening team of Super Lyan by Ryan Chetiyawardana, rising to Head Bartender.

Her achievements include being crowned in several bartending competitions. Her work has also been featured in Difford's Guide, The Spirits Business, and Drink Magazine Asia. Through creativity, leadership, and an inclusive approach, Zana continues to shape exceptional bar experiences and inspire the global bartending community.

ABOUT WORLD CLASS

World Class is on a mission to inspire people to drink better and create unforgettable experiences in the process. Whether at home or in a bar, World Class encourages consumers to think and care about what, where and how they drink, and in doing so, discover the best of cocktail culture.

World Class has supported, trained and inspired over 500,000 bartenders across the globe over the past seventeen years, while partnering them with the world's finest spirits. It is the authority on the global drinks industry for information on the latest drinks, trends, cocktail recipes and industry insight.

ABOUT DIAGEO

Diageo is a global leader in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, J&B and Buchanan's whiskies, Smirnoff and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.

Diageo is a global company, and our products are sold in nearly 180 countries around the world. The company is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO). For more information about Diageo, our people, our brands, and performance, visit us at www.diageo.com. Visit Diageo's global responsible drinking resource, www.DRINKiQ.com for information, initiatives, and ways to share best practice.

Crafting iconic drinks chosen for life's moments.

Copyright 2026 GlobeNewswire, Inc.

SINGAPORE, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha"), a leading institutional digital asset financing platform, today announced that its wholly owned subsidiary, Antalpha Capital (HK) Limited, has entered into a share subscription agreement with Aurelion Inc. (NASDAQ: AURE) ("Aurelion" or the "Company").

Under the agreement, Antalpha, through Antalpha Capital (HK) Limited, will subscribe for 952,381 newly issued Class B ordinary shares of Aurelion at a price of US$2.10 per share, for aggregate gross proceeds to Aurelion of approximately US$2 million (the "Subscription"). The Subscription is expected to close as soon as practicable, subject to customary closing conditions and a long-stop date of December 21, 2026.

Antalpha currently holds 31.7% of the ordinary shares of Aurelion's issued and outstanding shares, based on Aurelion's outstanding shares/pre-funded warrants/primary warrants, representing approximately 77.5% of Aurelion's total voting power. Upon completion of the subscription, Antalpha is expected to hold approximately 33.4% of Aurelion's issued and outstanding shares, based on Aurelion's outstanding shares/pre-funded warrants/primary warrants representing approximately 78.8% of Aurelion's total voting rights.

"Increasing our investment in Aurelion reflects our continued confidence in its strategy and the long-term potential of tokenized gold," said Paul Liang, Chief Financial Officer of Antalpha. "Aurelion's focus on digital gold infrastructure complements our expertise in financing and risk management. Through this additional commitment, we are supporting the development of practical institutional applications for tokenized gold, with disciplined execution and long-term shareholder value as our priorities."

"Antalpha's continued support as our controlling shareholder reinforces its commitment to Aurelion's next phase of development," said Frank Zheng, Chief Executive Officer of Aurelion. "Upon closing, this investment would provide additional financial flexibility as we advance our digital gold business. Our focus is on building the technology and risk-management capabilities that institutions need to use tokenized gold with confidence."

About Antalpha

Antalpha is a leading fintech company specializing in providing financing, technology, and risk management solutions to the Web3 industry. Antalpha offers Bitcoin supply chain and margin loans through the Antalpha Prime technology platform, which allows customers to originate and manage their digital assets loans, as well as monitor collateral positions with near real-time data. Building on this foundation, Antalpha is also exploring AI-powered tools to help users navigate the digital asset space more effectively.

About Aurelion

Aurelion is a publicly listed company building a digital gold risk and technology infrastructure around XAU₮, on-chain gold backed by physical LBMA bars. Combining the characteristics of physical gold with the efficiency of blockchain technology, XAU₮ serves as the foundation of Aurelion's digital gold treasury strategy.

The Company is committed to the prudent management and efficient utilization of its proprietary digital gold holdings, while providing risk management and technical support for selected tokenized gold initiatives. Through its technology-driven approach, Aurelion seeks to contribute to the responsible development and broader adoption of digital gold and tokenized asset solutions.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. Statements that are not historical facts, including statements about Antalpha's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties.

Further information regarding these and other risks is included in Antalpha's filings with the SEC. All information provided in this press release is as of the date of this press release, and Antalpha does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Copyright 2026 GlobeNewswire, Inc.

HANOI, VIETNAM - Media OutReach Newswire - 23 October 2026 - Vietnam's healthcare spending is forecast to reach US$34.1 billion by 2028, while most medical equipment, finished medicines and active pharmaceutical ingredients are still imported; at the same time, policy is shifting its focus towards prevention and screening.

Global Health Week Vietnam 2027 takes place against this backdrop, where healthcare facilities, businesses and investors come together to discuss solutions, partnerships and investment in Vietnam.

Resources grow, and so does the need for innovation

Speaking at a workshop of the Health Strategy and Policy Institute on 24 December 2025, Dr Ong The Due said Vietnam's healthcare spending has grown by an average of around 7?8% a year: from US$17.4 billion in 2019 to an estimated US$27.5 billion in 2025, and is forecast to reach US$34.1 billion in 2028.

This growth comes with a shift in the direction of health care. Resolution 72-NQ/TW of the Politburo (September 2025) on protecting, caring for and improving people's health calls for a decisive shift from treatment-centred care to proactive prevention and continuous, life-course health care. Directive 17/CT-TTg of the Prime Minister (May 2026) calls for all citizens to receive a free periodic health check-up or screening at least once a year and to have a personal electronic health record by the end of 2026.

Funding has been allocated: the National Assembly has approved the investment policy for the National Target Programme on health care, population and development for 2026?2035 (Resolution 262/2025/QH15), with total funding of VND 88,635 billion (about US$3.4 billion) for 2026?2030, of which VND 47,692 billion is public investment capital. The second campus of Bach Mai Hospital (1,000 beds) has a 2025 procurement plan of 47 equipment packages worth more than VND 338 billion (about US$13 million).

The professional foundation is in place: Vietnam's essential health service coverage index reached 71 out of 100 in 2023, according to the World Bank; Vietnamese doctors have mastered multi-organ transplantation, fetal cardiac intervention and robotic surgery, performing more than 1,000 organ transplants a year. Yet at many facilities, equipment has not kept pace with the capabilities of the workforce.

The gap is clearly visible in the equipment market: according to the U.S. International Trade Administration (ITA), citing BMI forecasts, Vietnam's medical device market could grow from US$1.9 billion in 2024 to US$2.8 billion in 2029, while around 90% of equipment is still imported. Procurement therefore has to go hand in hand with technical transfer, consumables supply, data integration, maintenance and post-handover support.

The pharmaceutical sector faces a similar challenge: Vietnam imports around 60% of finished medicines and 90% of active pharmaceutical ingredients (ITA), while the National Strategy for Pharmaceutical Industry Development (Decision 1165/QD-TTg of the Prime Minister) targets domestically produced medicines meeting around 80% of demand and 70% of market value by 2030, with domestic raw materials meeting 20% of demand - which calls for manufacturing technology, quality control and technology transfer agreements with clearly defined responsibilities.

International capital is already present: the 2024 Statistical Yearbook records 159 valid FDI projects in health and social assistance, with registered capital of nearly US$1.77 billion. In 2023, Thomson Medical Group completed the acquisition of the company that owns FV Hospital, with an initial payment of US$352.8 million, and Raffles Medical Group signed a conditional agreement to acquire a controlling stake in and participate in the management of the American International Hospital in Ho Chi Minh City; AstraZeneca has committed to invest US$360 million in Vietnam through 2030.

From hospital needs to technology choices

Rising demand, expanding capital flows and the push for higher service quality are opening opportunities in Vietnam for global technology, infrastructure and solution providers; the next challenge is choosing the right solutions and putting them into operation. Global Health Week Vietnam 2027 takes place from 5 to 7 April 2027 at the Vietnam Exposition Center (VEC), Hanoi, co-organised by VEC and dmg events, and comprises three concurrent specialised exhibitions and conferences: Global Health Week Vietnam 2027 (health systems and care delivery), Laboratory & Diagnostics Vietnam 2027 (laboratory and diagnostics) and BioPharma Vietnam 2027 (pharmaceuticals and biotechnology).

The event targets around 30,000 attendees from more than 120 countries, including healthcare leaders, clinicians, administrators and decision-makers, among them 3,000 conference delegates; more than 500 exhibitors, more than 10 country pavilions and more than 300 domestic and international speakers.

Global Health Week Vietnam 2027 presents solutions in hospital infrastructure, operations, digital health, AI, preventive care and population health, alongside the high-level Global Health Week Vietnam Forum on health policy and investment, and the Innovation Theatre showcasing technology.

Laboratory & Diagnostics Vietnam 2027 addresses the need to strengthen testing capacity as screening expands, with the Diagnostics Innovation Zone covering molecular diagnostics, point-of-care technologies and AI-driven laboratory systems. BioPharma Vietnam 2027 focuses on manufacturing technology, quality standards and technology transfer, with Partnership & Investment Meetings bringing together manufacturers, investors and technology partners.

A need may begin at a patient's bedside, while the answer may lie half a world away from Vietnam. With fast-growing demand, capital already in place and an increasingly clear role in Asia's healthcare supply chain, Vietnam is a market that international suppliers are turning to. Global Health Week Vietnam 2027 creates more face-to-face meetings to close that distance: bringing technology closer to Vietnam's hospitals and patients and, from Vietnam, helping shape the future of healthcare in Asia.

Details and stand booking are available on each exhibition's website:

- Global Health Week Vietnam 2027: https://www.globalhealthweek-vietnam.com/

- Laboratory & Diagnostics Vietnam 2027: https://laboratoryandiagnostics-vietnam.com/

- BioPharma Vietnam 2027: https://biopharma-vietnam.com/

About the Vietnam Exposition Center (VEC)

The Vietnam Exposition Center (VEC) in Dong Anh, Hanoi is an international-standard exhibition and convention complex with a total area of around 900,000 m?, comprising indoor exhibition halls, outdoor squares, a convention centre, a theatre and stadiums. VEC hosted the National Achievements Exhibition 2025, which welcomed more than 10 million visitors in 19 days, and specialised trade weeks such as Vietnam Industry and Technology Week 2026 (VITW 2026).

Website: https://vec.global/

About dmg events

Founded in 1989, dmg events organises more than 80 events a year in more than 20 countries, attracting over 1 million visitors and delegates, with flagship events including ADIPEC, Gastech, EGYPES, Big 5 Global and Abu Dhabi Global Health Week. Website: https://www.dmgevents.com/

The issuer is solely responsible for the content of this announcement.

Hashtags: #VEC

*Clera Cera is a new science-led dermatological skincare brand, with nine products for everyday use.

*Co-developed with Singapore's National Skin Centre, a member of NHG Health, with ingredients that fortify the Asian skin's natural barrier and lightweight textures suited to Asia's heat, humidity and pollution.

*Its Skin Barrier Resilience System combines Derma-Clera, powered by Cynanchum Atratum (Bai Wei) extract, with five skin-identical ceramides to Replenish, Repair and Relieve Asian skin.

*Clera Cera was shaped by listening sessions and usage tests from more than 18,000 consumers across five Asian markets

HONG KONG SAR - Media OutReach Newswire - 23 October 2026 - Clera Cera, a new science-led dermatological skincare brand made for Asian skin and designed for everyday use, launches today at Guardian and Mannings. Co-developed with an expert team from Singapore's National Skin Centre, a member of NHG Health, Clera Cera brings dermatologist-developed skin barrier care into everyday retail.

Heat, humidity and pollution can take a toll on Asian skin, and everyday habits such as frequent cleansing and use of harsh products strain the skin barrier. Research1 also suggests that Asian skin has a thinner outer layer, which makes the barrier more vulnerable to irritants. With about one in three people in Asia reported to have sensitive skin2, the need for skincare designed for these realities is growing.

The launch of Clera Cera comes amid growing consumer demand across Asia for skincare that soothes sensitive skin, supports daily preventive care and is both science-backed and accessible. Clera Cera's mission is simple: to make effective, dermatologist-developed skincare designed for Asian skin part of everyone's daily routine.

"Clera Cera marks a new chapter for Guardian and Mannings. We are going beyond selling health and wellness products to creating them, with the clinical expertise of NHG Health's National Skin Centre behind us. It takes dermatology beyond clinical walls to a shelf where customers already shop, at a price that fits an everyday routine. This is the one of the many ways we continue to democratise wellness and it's what being our customers' Trusted Wellness Advisor means," said Curtis Liu, Chief Executive Officer, Health and Beauty, DFI Retail Group.

Clera Cera is the first initiative focused on dermatological skin care under the long-term partnership between DFI Retail Group and NHG Health announced in October 2025 to strengthen preventive care and widen access to everyday health and wellness. It is the first time a public healthcare cluster in Singapore has worked with a retailer to make safe and effective health solutions backed by clinical research even more accessible to the public in Singapore and across Asia.

"One of NHG Health's mission is to enhance the health of the population we serve. Partnerships like this allow us to translate clinical knowledge and research into everyday health. What makes this collaboration with DFI Retail Group meaningful is that we are able to bring evidence-based care to people where they are, beyond the hospital and clinic. Skin health is only the starting point. The wider opportunity is in areas such as elderly nutrition and home care, which will be explored for our ageing population," said Professor Benjamin Seet, Group Chairman Medical Board (Research), NHG Health.

A Science-led Skin Barrier Resilience System to Replenish, Repair and Relieve Asian Skin

Clera Cera was co-developed with a leading dermatology team at Singapore's National Skin Centre, a member of NHG Health. Associate Professor Tey Hong Liang, who led the formulation of it with Ms. Winnie Choo, Principal Pharmacist, is ranked among the world's top 2% of scientists by Stanford University and Elsevier. The team's work spans more than 55 healthcare-related national and international awards, grants and fellowships for advancing skin health.

The core essence of Clera Cera's formulation is a Skin Barrier Resilience System that combines two key components:

Derma-Clera, powered by Cynanchum Atratum (Bai Wei) botanical extract, that helps soothe the skin;

Five skin-identical ceramides that help replenish essential lipids within the skin barrier, supporting hydration, repair and strength.

Working like building blocks, they help reinforce the Asian skin's natural barrier by supporting healthy barrier in three ways:

Replenish: Restores skin hydration, with moisture-attracting ingredients such as saccharide isomerate

Repair: Strengthens the skin barrier with five skin-identical ceramides

Relieve​: Soothes the skin with Derma-Clera, ​powered by a Cynanchum Atratum (Bai Wei) extract.

"Exposure to pollution and a warm, humid climate, together with frequent cleansing and use of harsh products weaken the protective barrier of the Asian skin over time. In our clinics, we often see this in patients with sensitive skin. The barrier depends on natural lipids such as ceramides, and it is best supported by gentle, consistent care, using lightweight formulations that people find comfortable applying every day,"said Associate Professor Tey Hong Liang, Clinical Director of the Centre for MedTech and Innovations, NHG Health, and Senior Consultant Dermatologist, National Skin Centre.

Made for Asian skin with feedback from Asian consumers

Shaped by listening sessions and usage tests from more than 18,000 consumers across Hong Kong, Indonesia, Malaysia, Singapore and Vietnam, Clera Cera overcomes common frustrations such as use of artificial fragrances and having sticky textures. The affordable, clean formula is designed for sensitive skin in humid climates.

The nine-product range spans body, face, targeted serums, and sun care made for Asian skin. Clera Cera is available now in Singapore, exclusively at Guardian Health & Beauty stores and online, and selected NHG Health pharmacies. Rollout in Brunei, Chinese mainland, Hong Kong, Indonesia, Malaysia, Macau and Vietnam will follow, reaching eight markets across Asia, at more than 1,500 Guardian and Mannings stores and online.

Body Care

The lineup features the Gentle Hydrating Cleanser alongside the Skin Relief Moisturising Lotion, both suitable for sensitive, eczema-prone skin and babies from three months old. Both are formulated with the ingredient, saccharide isomerate, which provides 24-hour hydration in the non-soap cleaner and 72-hour hydration in the lotion. In a home user trial involving 104 participants, 89% of panellists agree that the lotion soothes skin in just three minutes.

Face Care

Daily facial care includes the Micellar Water Gentle Makeup Remover, Hydrating Foaming Face Wash, and Barrier Hydrating Aqua Cream. Engineered to prevent clogged pores in humid climates, the line removes waterproof makeup with micellar water while the foaming wash and aqua cream containing the ingredient saccharide isomerate delivers up to 24 hours and 72 hours of skin-balancing moisture respectively.

Target Serums

Intensive treatment is delivered through the B3 TXA Brightening Dark Spot Serum and Retinol Age Defense Serum. These contain active ingredients that target specific skin concerns while supporting the skin barrier.

Suncare

Broad-spectrum protection features two mineral formulas: the Daily Defense Physical Sunscreen Serum SPF 50 PA+++ and the Tone Up Physical Sunscreen Serum SPF 50 PA+++. Powered by Nano Zinc Oxide, both sunscreens reflect UVA/UVB rays and block 95% of blue light, featuring 40-minute water resistance.

[1] Infant Skin Barrier, Structure, and Enzymatic Activity Differ from Those of Adult in an East Asian Cohort. BioMed Research International. 2018. Liu Q, Zhang Y, Danby SG, Cork MJ, Stamatas GN.

[2] Chen W, Dai R, Li L. The prevalence of self-declared sensitive skin: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2020;34(8):1779-1788. DOI: 10.1111/jdv.16166 Meta-analysis comprising 26 studies and 51,783 participants globally, with a pooled Asian prevalence of 31% (95% CI 16?45%).

Clera Cera

Clera Cera is a science-led dermatological skincare brand made for Asian skin. Co-developed with the National Skin Centre, NHG Health, Singapore, the brand combines deep Asian skin expertise with dermatological science to deliver effective yet gentle care for everyday Asian life. Its Skin Barrier Resilience System is designed to support the way Asian skin naturally repairs itself, helping to replenish, repair and relieve for a strong, resilient Asian skin barrier.

The issuer is solely responsible for the content of this announcement.

Hashtags: #cleracera #Guardian #Mannings #dermatologist #skincare

QashierGM works from each merchant's own sales, payouts and menu, and gets routine work done with the owner's approval. With Crew, Qashier's new team chat, anyone on the team can tag @GM to get things done, and QashierGM acts only within each person's role.

SINGAPORE - Media OutReach Newswire - 23 October 2026 - Qashier, the unified merchant operating system serving more than 25,000 businesses across Southeast Asia, today launched QashierGM, an AI general manager that works with a merchant's whole team. Available at no additional cost to all Qashier merchants in Singapore,

QashierGM lives in QashierHQ, the web and mobile app (Android and iOS) merchants use to manage their sales, payouts, products and staff. Owners can ask it about sales, payouts and products in plain language. Merchants on the Qashier plan also get Crew, a new team chat where staff can bring QashierGM into any conversation by tagging @GM. Malaysia, Thailand and the Philippines follow in November.

Because QashierGM works directly from each merchant's own transactions and settlements, it can do what a general-purpose chatbot cannot: explain, line by line, why a payout is lower than the day's sales, or show which outlet is underperforming this week. Owners get answers grounded in their actual operations, without piecing together reports.

"Most small business owners can't afford a general manager, so they become one after closing, going through reports at midnight," said Christopher Choo, Co-Founder and CEO of Qashier. "QashierGM is the manager they never had. It already knows the business, takes on the routine work and never makes a change without asking. With Crew, it now works alongside the whole team, not just the owner."

The launch follows an open beta that began in September with merchants ranging from single-outlet caf?s and shops to multi-outlet chains, with F&B operators the most active. Their most common questions were about sales trends, best sellers and payouts, and with the year-end festive season approaching, many are asking QashierGM to suggest festive promotions built around their most popular items.

Jun Rong, Operations Manager of Coexist Coffee Co., likens using QashierGM to talking to his store managers, only faster. "Running a caf? means wearing every hat, and the numbers usually wait until after closing. QashierGM already knows our sales, payouts and menu, so I just ask. When we plan a promotion, it suggests ideas based on what our customers actually buy, and nothing changes until I confirm. It feels like having a general manager who's been with us from day one."

QashierGM also takes routine admin off the owner's plate. An owner can ask it to update a price, mark an item as sold out or add a new product, and QashierGM shows a card with exactly what will change and where. Nothing goes live until the owner taps confirm. Multi-outlet operators can compare stores, spot the one underperforming and push a change to every store in one request. Store managers see and change only their own store. Owners can also set alerts in their own words, such as "alert me on any unusual refunds" or "tell me when the first staff clocks in", and QashierGM tells them when it matters.

Crew: the whole team, with QashierGM in the conversation

Crew, included in the Qashier plan and Enterprise plans, gives a merchant's team a work chat of its own, separate from personal messaging groups where messages get lost and former staff keep the history. Owners, managers, kitchen and floor staff get private direct messages, group chats by team or department, and announcements with read receipts. Anyone can tag @GM to check a number, update an item or send a customer an invoice with a payment link. QashierGM acts only with the permissions of the person who tagged it, sends bigger changes to whoever can approve them right in the chat, and posts an update when an invoice is paid. It only sees the conversations it is tagged into.

On a typical day, a floor staff member can mark a dish sold out, a manager can approve a price change from her phone, and an owner can send an event deposit invoice and see it paid, all in the same app. Crew and QashierGM work in all major languages used across the region, including English, Mandarin Chinese, Malay and Thai.

Connectors to third party apps such as Gmail and Google Business Profile arrive in November, extending QashierGM beyond Qashier to supplier emails, customer enquiries and Google reviews. "A good general manager handles the work wherever it lands, not just inside one system," added Choo. "This is the first step."

Qashier processes more than US$1 billion in annualised payment volume for over 25,000 merchants across Singapore, Malaysia, Thailand and the Philippines. The company has been profitable since December 2025 and raised US$6.125 million in Series A+ financing in June 2026. QashierGM is available now to all Qashier merchants in Singapore through QashierHQ on web, Android and iOS, at no additional cost. Crew is included in the Qashier plan and Enterprise plans. Both launch in Malaysia, Thailand and the Philippines in November. To learn more, visit https://qashier.com/sg/.

Qashier Pte. Ltd.

Qashier is a unified merchant operating system that brings together payments, business software, embedded financial services and customer engagement tools on one platform. Operating across Singapore, Malaysia, Thailand and the Philippines, Qashier supports more than 25,000 SMEs with an integrated ecosystem built for Southeast Asia's digital economy. Qashier is licensed by the Monetary Authority of Singapore as a Major Payment Institution. Founded in Singapore in 2019, Qashier gives merchants an AI general manager, QashierGM, and a team chat, Crew, through QashierHQ.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Qashier #QashierGM

https://qashier.com/sg/

https://www.linkedin.com/company/qashier/

https://www.facebook.com/Qashier

https://www.instagram.com/qashier.sg/

Tiktok: https://www.tiktok.com/@qashier.sg

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia

Highlights

Collaboration aims to accelerate precision oncology research in Australia

Combines Fortrea's experience in oncology clinical trials with Omico's Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program

Together, Fortrea and Omico offer more efficient investigator site selection and faster patient access by connecting patients with relevant biomarker-driven clinical trials

DURHAM, N.C. and SYDNEY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization ("CRO"), and Omico, Australia's leading precision oncology screening and trial matching organization, today announced a collaboration to accelerate precision oncology research by helping connect cancer patients to biomarker-matched clinical trials.

By combining Omico's precision oncology network with Fortrea's scientific and clinical trial experience, the joint effort aims to improve study planning, site selection and patient recruitment to expand access to biomarker-driven oncology research globally.

Through this initiative, Omico will support Fortrea's clients in their oncology drug development needs by providing access to patient population insights, including genomic profiling, trial-matching capabilities, real-world oncology data and patient referral pathways in Australia, a key country both for early and late phase Oncology clinical research activities. The collaboration will combine Fortrea's oncology drug development experience with Omico's flagship Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program, the largest cancer genomics initiative in Australia. PrOSPeCT is designed to provide molecular profiling and help match patients to biomarker-driven clinical trials and targeted therapies.

"Our collaboration with Omico is about seeking to reach the right patient for the right study as quickly as possible," said Oren Cohen, M.D., Chief Medical Officer at Fortrea. "Modern oncology development demands ever-greater precision to match specific cancers with the therapies most likely to benefit patients, and to do so as quickly as possible. Our work with Omico accelerates our ability to identify the right patients for biomarker-driven studies in Australia and help advance precision medicine for people with cancer."

Omico has built one of Australia's most extensive precision oncology ecosystems, combining molecular profiling, real-world evidence, cohort research programs and a nationwide network of investigators and clinical sites. Omico has reported more than 23,000 consented patients within its clinic-genomic databases and has received referrals from more than 1,600 clinicians across Australia.

"Australia is well positioned to support global biomarker-driven clinical trials, through Omico's established national precision oncology research infrastructure, expertise and networks," said Professor David Thomas, Chief Science and Strategy Officer at Omico. "By combining our national data and trial matching capabilities with Fortrea's global clinical development expertise, we can help international sponsors identify relevant patient populations, plan trials more effectively and support targeted recruitment."

Fortrea's oncology expertise is underpinned by thousands of operational professionals and supported by more than 50 oncology physicians on staff. This collaboration comes at a time when modern oncology drug development has accelerated the focus on precision medicine, biomarker-driven development and targeted patient identification. Working together, Fortrea and Omico can offer more efficient site selection and the ability to match patients with appropriate studies tied to their unique genomic data, enabling more people to participate in studies tailored to their specific condition in Australia.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn and X and Bluesky.

About Omico

Omico is an independent, national, not-for-profit research organisation changing the way we fight cancer. We work to improve outcomes for Australians with cancer by providing equitable access to precision oncology and translating scientific advances into clinical care and research, and generating the evidence needed to inform health policy and system reform. Working with Australia's leading cancer institutes, researchers, clinicians, industry partners, advocacy groups and government, we are accelerating molecular profiling, biomarker-led clinical trials, personalised cancer risk management and real-world evidence.

About PrOSPeCT

PrOSPeCT is Australia's largest precision oncology initiative. Delivered by Omico and a national network of healthcare, research and industry partners, it provides eligible Australians with access to molecular profiling and matching to biomarker-led clinical trials and therapies (at no cost to the patient), while generating clinical, genomic, treatment and outcomes data to advance research, improve cancer care and inform future health policy.

Copyright 2026 GlobeNewswire, Inc.

New capabilities of the Rhino Federated Computing Platform (Rhino FCP) connect securely to the systems inside the perimeter and make federated pipelines repeatable across every site.

BOSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- At the Federate AI Summit, Rhino Federated Computing announced Trusted Integrations and Workflows, two capabilities on the Rhino Federated Computing Platform (FCP) that that turn federated AI pilots into production programs built on the enterprise's existing technology.

Published research on federated learning has grown more than 13-fold since 2020, and healthcare and life sciences is its fastest-growing application, according to a Rhino Federated Computing analysis of the OpenAlex research database. That body of work has settled whether AI can run on data that cannot move. Scaling it poses a different problem.

A pilot runs on one team, one dataset, and hand-written scripts, walled off from the rest of the enterprise. A program must repeat that work for every project at every site, draws on the data platforms and systems the enterprise already runs, and answers to stakeholders who ask what ran, what left each site, and what resulted. When every initiative means rebuilding by hand and every connection requires a security exception and custom integration, programs stall at the pilot. Agentic AI raises the stakes further: no enterprise will let AI act on its data until those actions are scoped and reviewable.

Trusted Integrations lets enterprises put the technology they already own to work on federated projects. Each Rhino Client is built to open an approved, scoped connection to systems inside the customer's secure perimeter, from FHIR servers and cloud data platforms to databases, object stores, private model serving, secrets managers, and managed health data services.

Customers keep control of their source data and networking. Data can move in either direction: a team can pull source data from a cloud data platform into the Rhino Client, or send approved context to a private model endpoint for an AI agent. Only what the integration allows crosses the connection, and the connection stays open only while the code that needs it runs.

Workflows turn multi-step federated work into software that teams build once, share, and run everywhere. A research network, for example, can publish one cohort-building Workflow and run it at every member hospital, so a data refresh or a twentieth site no longer requires starting over. Because each site runs identical steps, differences in results reflect the local data, not the method. Every Workflow run records the exact pipeline it executed, with each task's logs and outputs, so governance is embedded. The same structure makes Workflows a natural boundary for AI agents, which act only through steps a team has defined and can review.

Together, the two capabilities extend Rhino Data Activation and Rhino Federated Intelligence, the single-party and multi-party solutions built on the Rhino FCP. A drug discovery consortium can deploy fine-tuned models through each member's private model serving environment. A hospital can harmonize refreshed clinical data locally with Rhino's Data Harmonization Engine, then send only an approved FHIR payload to the FHIR server of its choice. A bank can prepare AI-ready datasets and send fraud assessments to the systems its investigators already use.

"Our customers have proven that federated AI works, so their ambitions are growing. They want it to draw on the technology they've already invested in and to deliver value continuously," said Antoni Abella Vendrell, VP of Product for Rhino Federated Computing. "Trusted Integrations and Workflows give our enterprise customers the automation and direct access to core systems to run federation within an enterprise context."

Trusted Integrations and Workflows are available now to Rhino FCP customers. To see both in action, request a demo with the experts at Rhino.

About Rhino Federated Computing

Rhino Federated Computing is a leader in commercial-grade federated AI and computing. We enable highly-regulated enterprises to activate the full value of sensitive data with full privacy preservation across internal and external silos. Our customers can run any workload, from analytics and model training to agents and AI, across their federated intelligence networks with complete transparency, control, and governance. By bringing code to the data rather than centralizing sensitive information, Rhino empowers life sciences, healthcare, financial services, and other industry leaders to collaborate securely, accelerate innovation, and deploy impactful AI at scale. To learn more, please visit www.rhinofcp.com or follow us at www.linkedin.com/company/rhinofc/.

Copyright 2026 GlobeNewswire, Inc.

AUSTIN, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE) -- The Del Valle ISD Education Foundation has been named the winner of the F1 Allwyn Global Community Award at the 2026 FORMULA 1 MSC CRUISES UNITED STATES GRAND PRIX in Austin, Texas.

The non-profit, which works to enhance educational opportunities and empower students in the Del Valle community in Texas, has been awarded EUR100,000 from Allwyn, the lottery-led entertainment company.

The donation will directly fund the 'Fast Track' initiative to expand teaching grants, student scholarships, and STEM opportunities for 12,000 local students.

Despite living in the literal shadow of the Circuit of the Americas (COTA) and high-tech industry, 85% of students in the Del Valle community live in underserved communities and face systemic challenges which prevent them from accessing local prosperity. The Del Valle ISD Education Foundation aims to change this reality by leveraging proximity to COTA and other opportunities - tackling the financial, logistical, and infrastructural barriers that stand between local youth and successful, high-tech futures.

The Fast Track initiative, which will be funded by the donation from Allwyn, is a ground-up, comprehensive workforce development plan. Rather than just offering basic career awareness, the program actively bridges the gap between high school classrooms and Austin's thriving technology and engineering sectors. By eliminating cost barriers for the tools students need to thrive, funding STEM innovation grants focused on racing and technology, and arranging direct industry exposure through workshops and field trips, Fast Track delivers economic opportunity for students and their families - while also creating a sustainable local talent pipeline for hi-tech businesses in the area.

The Del Valle ISD Education Foundation's relationship with Formula 1 will continue to make a lasting impact through this Award. Situated right next door to COTA, the foundation connects students to the world-class engineering, logistical excellence, and innovation happening on the track. For young people whose daily environment presents significant financial hurdles, the Grand Prix represents more than speed - it serves as a direct, tangible inspiration for what they can achieve in STEM and tech industries.

Tatiana Jouanneau, Group Chief Brand Officer at Allwyn and F1 Allwyn Global Community Award judge said: "We are incredibly proud to support the Del Valle ISD Education Foundation. We created the F1 Allwyn Global Community Award to support initiatives that generate deep, lasting empowerment in the communities that surround the Grands Prix. The Del Valle project stood out for its direct route toward economic mobility for thousands of young people in the local area, perfectly capturing the spirit of the Award."

Ellen Jones, Head of ESG at Formula 1 and F1 Allwyn Global Community Award judge said: "At Formula 1, we operate on precision and data-driven performance, and it was clear that this team shares that same disciplined mindset. By anchoring their 'Fast Track' project in tangible, trackable KPIs, they've proven they are as committed to long-term accountability as they are to immediate support. We are proud to back an initiative that understands exactly how to turn investment into real, sustained change for the students who need it most."

Josh Thomas, Executive Director, Del Valle ISD Education Foundation, added: "We're incredibly excited to receive the F1 Allwyn Global Community Award. Our 12,000 Del Valle students live alongside a fast-growing corridor of racing, robotics, and hi-tech innovation, but poverty and systemic barriers stand between them and those careers. This Award allows us to launch Fast Track, a comprehensive initiative funding the internships, scholarships, and wraparound support that will help Del Valle students access these life-changing opportunities."

The Del Valle ISD Education Foundation is the fifth organisation to be recognised by the F1 Allwyn Global Community Award in 2026, following the British Starlight Children's Foundation; Canadian charity La Tabl?e des Chefs; Austrian non-profit Sindbad Mentoring, and Dutch charity Spieren voor Spieren. More organisations will be recognised across the Grand Prix race locations this season in Mexico City and Las Vegas. After all the season's winners have been announced, Formula 1 fans will have the chance to cast their vote on their favourite winning initiatives as part of Allwyn's plan to bring these fans closer to the programme.

Notes to editors

About Allwyn

Allwyn AG is a multi-national gaming entertainment company, lottery-led and with leading market positions and trusted brands across Europe and North America, listed on Euronext Athens. Its purpose is to make play better for all by focusing on innovation, technology, player safety and returning more to good causes across a growing casual gaming entertainment portfolio.

About Allwyn's partnership with Formula 1

The multi-year partnership with Formula 1 represents a drive towards increased global awareness for Allwyn, with the sport's 24 races across the globe, 750 million fans, and 96 million social media followers, as well as its reach across broadcast channels and entertainment outlets.

The partnership will reinforce Allwyn's position as an international brand driving community impact across the world, in support of its global growth plans.

At the heart of the partnership is the development of initiatives that will support the company's ambition to be a positive contributor to society globally. With Allwyn and Formula 1 equally committed to empowering fans and local communities, the partnership will give Allwyn the opportunity to utilise the sport's ever-growing international fan base to celebrate those making positive change, sharing these inspiring stories on a global level.

About Formula 1

Formula 1 racing began in 1950 and is the world's most prestigious motor racing competition, as well as the world's most popular annual sporting series. Formula One World Championship Limited is part of Formula 1 and holds the exclusive commercial rights to the FIA Formula One World Championship. Formula 1 is a subsidiary of Liberty Media Corporation (NASDAQ: FWONA, FWONK, LLYVA, LLYVK) attributed to the Formula One Group tracking stock. The F1 logo, F1 Formula 1 logo, Formula 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.

Further information about the F1 Allwyn Global Community Award, including eligibility criteria and the selection process, can be found on our website: https://www.allwyn.com/responsibility/community-award.

About Del Valle ISD Education Foundation

The Del Valle ISD Education Foundation is an independent non-profit organisation dedicated to opening pathways of opportunity for students and educators across the Del Valle Independent School District. Located directly adjacent to major innovation hubs in Southeast Austin, the Foundation mobilizes community partnerships and philanthropic investment to drive academic achievement and long-term economic mobility. Through student scholarships, innovative teaching grants, family support resources, and ground-up workforce development initiatives like "Fast Track," the Foundation works to ensure that the rapid economic growth in Central Texas translates into shared prosperity for local youth, empowering them to excel in high-wage, cutting-edge careers. For more information, visit https://www.dvisdef.org.

Copyright 2026 GlobeNewswire, Inc.

WUHU, China, Oct. 22, 2026 (GLOBE NEWSWIRE) -- On October 22, during the global user ecosystem activities held alongside the 2026 Chery International User Summit, Chery launched the "Ride Green Life" lakeside low-carbon cycling ride. Under the shared vision of "One nature, one future," the initiative calls for integrating nature conservation, biodiversity and sustainable action into product experiences, user engagement, organizational decision-making and everyday life.

Beyond the high-tech exhibition area, an 10.6-kilometer low-carbon ride had just concluded. As part of the call to action, international media, industry partners and user representatives from around the world cycled around the park, scanned codes to record their carbon footprints and took part in the initiative in the most direct way.

Ride Green Life

During the event, IUCN highlighted its four-year programme Nature 2030: One Nature, One Future, which guides the Union's work to realise its vision of "a just world that values and conserves nature," and aligns with the United Nations 2030 Agenda for Sustainable Development and the Kunming-Montreal Global Biodiversity Framework. Since launching the global "Cherish the Nature" partnership with IUCN in 2024, Chery and IUCN have continued to build a cooperation mechanism around nature conservation, environmental education and public engagement, delivering impact in safeguarding biodiversity, enhancing climate resilience, and empowering communities.

At the Summit, Chery donated Chery-branded jerseys signed by Robert Lewandowski, Chery's Global Brand Ambassador and UNICEF Poland Ambassador, to UNICEF China.

Since 2023, Chery Group has committed US$12 million to support UNICEF's global education programmes across Mexico, China, South Africa, T?rkiye, Indonesia, and Viet Nam. Chery also participated for the first time in a high-level meeting on the Learn AI Global Compact during the UN General Assembly High-Level Week, advocating technology- and innovation-driven education transformation.

Alongside this expanding green ecosystem, Chery's Volt-dragon Charger and V2G Smart Charging Center highlighted its advances in energy management. The megawatt-level ultra-fast charging technology can deliver "5 minutes of charging for 500 kilometers of range," while bidirectional V2G vehicle-to-grid interaction allows vehicles to charge during off-peak periods and feed electricity back to the grid during peak hours, transforming them into mobile storage units that can participate in urban grid dispatch.

*UNICEF does not endorse any company, brand, product or service.

Copyright 2026 GlobeNewswire, Inc.

WUHU, Tiongkok, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Persaingan antar-produsen otomotif dalam pengembangan teknologi cerdas kini semakin pesat dan tidak lagi terbatas pada kabin kendaraan. Kemampuan persepsi, pengambilan keputusan, dan pengendalian yang terus disempurnakan dalam dunia otomotif kini mulai merambah ke lingkungan rumah, layanan perkotaan, dan berbagai ruang fisik lainnya.

AiMOGA Robotics, merek AI berwujud milik Chery, membuka pemesanan awal (pre-order) global untuk Mobo, robot pendamping rumah tangga pertamanya, dalam acara peluncuran global di Wuhu. Peluncuran ini menandai langkah AiMOGA dari sektor layanan komersial menuju pasar robot rumah tangga bagi konsumen.

Didukung oleh agen cerdas MoAgent, Mobo memadukan kemampuan mengenali tata ruang rumah, interaksi alami, pengendalian gerakan seluruh tubuh, memori jangka panjang, serta arsitektur kolaborasi antara komputasi edge dan cloud. Hal ini memungkinkan Mobo secara mandiri membagi tugas-tugas jangka panjang menjadi beberapa tahapan serta beradaptasi dengan lingkungan rumah yang kompleks. Dengan 22 derajat kebebasan gerak tubuh, Mobo mampu mengenali anggota keluarga, mengingat preferensi mereka, serta memastikan privasi data terlindungi secara menyeluruh. Mobo dirancang untuk memenuhi tiga kebutuhan utama, yaitu perawatan dan pendampingan lansia, pendampingan anak-anak, serta perawatan seluruh anggota keluarga.

Dalam acara tersebut, 35 pengguna awal ditunjuk sebagai Global Angel User Experience Ambassadors pertama Mobo. Sejak debut di World Robot Conference pada bulan Agustus lalu, Mobo telah menarik minat lebih dari 10.000 calon pengguna di seluruh dunia.

AiMOGA berencana membangun jaringan awal yang mencakup 300 pusat pengalaman di seluruh dunia. Perusahaan juga akan mendukung mitra ekosistemnya di berbagai bidang, termasuk solusi, pemasaran digital, layanan keuangan dan asuransi, serta dukungan purnajual. AiMOGA juga berencana menghadirkan merek penyewaan robot berskala global yang melayani sektor layanan kesehatan, transportasi, pendidikan, keamanan, budaya, dan pariwisata.

AiMOGA juga memamerkan Mornine, robot humanoid untuk menyambut tamu di lingkungan bisnis kelas atas; Intelligent Security Robot R001 untuk patroli keamanan publik; Robotic Nurse RN001 untuk memberikan panduan kepada pasien; serta Argos, robot berkaki empat untuk inspeksi khusus dan pengoperasian di luar ruangan. Total pengiriman komersialnya telah melampaui 3.000 unit, dengan kegiatan bisnis yang menjangkau lebih dari 60 negara dan wilayah.

Bagi Chery, AI berwujud merupakan kelanjutan alami dari pengembangan teknologi otomotifnya. Dengan memanfaatkan kembali 100% rantai pasokan otomotif dan 70% teknologi Litbang yang dimilikinya, Chery memungkinkan AiMOGA menawarkan kualitas berstandar otomotif dengan harga terjangkau. Langkah ini juga secara signifikan menekan biaya uji coba dan produksi massal dibandingkan dengan perusahaan rintisan (start-up) yang mengembangkan teknologi dari awal.

CheryMind, model fondasi yang dikembangkan khusus untuk AI fisik di bidang tertentu, mendukung teknologi berkendara cerdas, pesawat yang terbang pada ketinggian rendah, robot AiMOGA, sistem energi cerdas, serta mesin pertanian cerdas. Dengan berkembangnya AI berwujud dari tahap prototipe menuju penerapan skala besar, Chery memanfaatkan rantai pasokan otomotif, kemampuan manufaktur, dan jaringan globalnya untuk menciptakan kurva pertumbuhan kedua.

Copyright 2026 GlobeNewswire, Inc.

JAKARTA, INDONESIA - Media OutReach Newswire - 22 October 2026 - The New Asia Forum (NAF) 2026 aims to mobilize US$30 billion in investment across the New Asia region by strengthening strategic partnerships and accelerating investment execution. Held under the patronage of President Prabowo Subianto, with Danantara Indonesia as a founding partner, the forum will take place on 3?4 December 2026 in Bali, Indonesia.

NAF 2026 is designed as an action-oriented platform connecting global investors, industry leaders, and policymakers to advance investment opportunities across strategic sectors. Moving beyond conventional economic dialogue, the forum seeks to translate investment interest into concrete commitments, financing structures, and measurable outcomes.

Pahala Nugraha Mansury, Managing Director of Global Relations & Communications at Danantara Indonesia, emphasized Asia's growing potential to attract long-term global capital amid shifting economic and geopolitical dynamics.

"Our focus is on encouraging long-term capital to recognize the many investment opportunities across Asian countries, because this is precisely where the center of gravity for growth lies. This will enable growth at scale, anchored by ASEAN and driven by Indonesia as the largest country in ASEAN," said Pahala.

The Asia-Pacific region currently accounts for nearly 60% of global economic growth. However, long-term international capital allocation to the region remains below its potential, presenting significant opportunities for greater investment collaboration.

NAF 2026 expects to convene more than 1,000 global leaders, feature over 100 speakers, and host more than 40 sessions involving sovereign wealth funds, institutional investors, development finance institutions, multinational corporations, and government representatives. Notable speakers include President Prabowo Subianto of Indonesia; Masayoshi Son, Chairman and CEO of SoftBank Group; Tshering Tobgay, Prime Minister of Bhutan; Kathleen Quirk, Chief Executive Officer of Freeport-McMoRan; Matteo Renzi, former Prime Minister of Italy; and Israfil Mammadov, Chief Executive Officer of the State Oil Fund of the Republic of Azerbaijan.

The forum will follow a two-day structure: Discovery & Diligence on 3 December, focusing on investment opportunities, feasibility, and transaction structures; and Action & Execution on 4 December, advancing capital commitments, strategic partnerships, and implementation milestones.

Eight priority sectors will anchor the discussions: strategic resources and downstreaming; energy and power; advanced mobility and manufacturing; digital infrastructure and AI; food and agribusiness; trade and connectivity; tourism and creative economy; and education and human capital.

As a founding partner, Danantara Indonesia will participate as a co-investor alongside global partners, supporting investment in strategic sectors and reinforcing Indonesia's role in regional economic transformation.

Through its transaction-focused approach, NAF 2026 aims to deliver preliminary investment agreements, bankable financing structures, and clearly defined implementation milestones. Investment commitments and progress will be tracked across subsequent editions to promote accountability, continuity, and tangible economic impact for Indonesia and the wider region.

The issuer is solely responsible for the content of this announcement.

Hashtags: #NewAsiaForum2026

MIAMI, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (the "Company" or "SKYX"), a highly disruptive platform technology company with over 120 patents and pending applications globally and over 60 lighting and home d?cor websites, with a mission to make homes and buildings safe and smart as the new standard, today provides a corporate update.

Highlights Recent Events

The combined SKYX and Deako pipeline is estimated at over 4 million units with an expected average selling price of approximately $50 per product.

SKYX's subsidiary Deako announced it will supply over 80,000 units to 1,000 homes of prominent builder Maronda Homes.

The Company recently signed an agreement to supply two 65 stories luxury Trump Towers with over 2.2 million SQF in one of India's leading tech cities Hyderabad, expecting to deploy tens of thousands of units.

SKYX recently announced it will supply its technologies during a renovation of a Marriott city center hotel in Durham, NC.

Maintaining Strong Cash Position

The Company reported $27.7 million in total cash, cash equivalents, and restricted cash as of the end of the second quarter of 2026 and continues to maintain a strong cash position to achieve its business goals, including achieving positive cash flow as it exits 2026.

The Company reported 10 consecutive quarters of year-over-year growth and expects to continue this pattern of quarterly growth.

SKYX Patented Turbo Heater Fan

Despite a very hot summer, SKYX's sales of its patented Turbo Heater Fan continued to grow during the summer with all retailers, including Home Depot, Lowe's, Target, Walmart, Costco, Amazon, Wayfair, and through SKYX's e-commerce platform of 60 websites.

The Company expects sales of its Turbo Heater Fan to grow significantly during the fall and winter seasons in both the retail and builder segments.

Due to increasing demand, SKYX intends to launch new designs in both larger and smaller sizes and in five different colors.

SKYX Deako Merger Highlights

Synergies

SKYX's full product line is expected to create an opportunity to increase Deako's revenue per home by up to fivefold.

Synergies between SKYX and Deako are expected to reduce annual cash expenses by over $6 million. In addition to expected revenues from sales, both SKYX and Deako use the razor-and-blades model and are expected to provide additional future revenues from upgrades, as well as recurring revenue opportunities from plug & play product interchangeability, AI services, monitoring, subscriptions, and licensing, among other sources.

The merger opens the door for Deako's products in SKYX projects, including Marriott and European hotels and Miami's $4 billion Smart City.

Stock Consideration & Lock-Up

In consideration for the merger, SKYX issued 25,000,000 shares of common stock, subject to a 12-month full lock-up (followed by quarterly leak-out releases at 12, 15, 18, and 21 months after the closing, with share sales subject to a Rule 10b5-1 trading plan).

Deako's Market Acceptance and Strategic Relations

Deako's lead investors include Paul Jacobs, former Chairman and CEO of Qualcomm; Deako's former board member Marwan Fawaz served as CEO of Nest (Google).

Deako has recently extended its supply agreement with leading builders D.R. Horton and Stone Martin.

Deako has shipped over 32 million units, including its smart plug-in wall switches, and generated over $26 million in revenue in 2025.

Deako is a leading technology supplier with over $26M in 2025 revenues and has shipped over 32 million units, including its smart home plug-in wall switches, to over 50 U.S. homebuilder customers, including D.R. Horton, Toll Brothers, Risewell Homes, Adams Homes, Maronda Homes, Shea Homes, and Schumacher Homes, among many others.

The merger between SKYX and Deako will enable SKYX to offer an A-to-Z AI and smart home plug & play solution for homes and buildings, including wall outlets, wall switches, and ceiling outlet boxes for smart home and safety products, lighting, ceiling fans, and smoke detectors, among others.

Most smart home solutions today require time-consuming and costly wired installation and address only part of the A-to-Z opportunity, while the combined company aims to offer a complete A-to-Z AI and plug & play smart home solution.

SKYX's Signed Agreements Prior to Merger with Builder / Hotel Segments

The Company recently signed an agreement to supply two 65 stories luxury Trump Towers with over 2.2 million SQF in one of India's leading tech cities Hyderabad, expecting to deploy tens of thousands of units.

SKYX recently announced it will supply its technologies during a renovation of a Marriott city center hotel in Durham, NC.

SKYX announced its technology will become a brand standard for European hotel developer Group OTT, a developer of over 250 hotels and buildings across Europe.

SKYX's future U.S. and international projects include Miami's new $4 billion Smart City and projects in North Carolina, Austin, San Antonio, South Florida, New York, Europe, Saudi Arabia, and Egypt.

SKYX is progressing toward its goal to become a brand standard for national and international hotel chains and builders.

Technology Licensing and Roadmap

SKYX has recently signed a licensing agreement for its advanced technologies with Eurofase, a leading lighting company in the U.S., Canada, and global markets.

SKYX expects to continue its licensing model for its vast patent portfolio as part of its safety code standardization efforts, as well as through licensing to leading tech companies.

SKYX will be launching a new AI-driven system and infrastructure for its e-commerce platform of 60 websites, expected to significantly increase its conversion rate and sales.

The Company secured U.S. and global strategic manufacturing partnerships with premier manufacturers in the U.S., Vietnam, Taiwan, China, and Cambodia.

Safety Standardization Mandatory Code and Insurance Exposure

SKYX's Safety Code Standardization Team is receiving support from a prominent new leader in connection with its government safety agency process for mandatory safety standardization of its electrical ceiling outlet/receptacle technology.

SKYX's code team is led by industry veterans Mark Earley, former head of the National Electrical Code (NEC), and Eric Jacobson, former President and CEO of the American Lighting Association (ALA). The Company's Safety Code Standardization Team believes it will garner assistance from additional safety organizations in its mandatory safety code standardization efforts based on the product's significant safety aspects. Mr. Earley and Mr. Jacobson were instrumental in numerous code and safety changes in both the electrical and lighting industries. Both strongly believe that, considering the Company's standardization progress, including ANSI / NEMA (American National Standards Institute / National Electrical Manufacturers Association) voting to approve its product specification and its technology being voted into 10 segments of the NEC Code Book, its technology has met the necessary safety conditions for becoming a ceiling safety standardization requirement for homes and buildings.

The Company strongly believes its products can save insurance companies many billions of dollars annually by minimizing risks (e.g., reducing fires, ladder fall injuries, and electrocutions). Management expects that insurance companies will use the Company's range and variations of its safe advanced plug & play products to reduce their exposure and minimize their risks. 

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced, safe, smart and AI platform technologies, with over 120 U.S. and global patents and patent pending applications. Additionally, the Company owns 60 lighting and home d?cor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://www.skyx.com/ or follow us on LinkedIn.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as "aim," "anticipate," "believe," "can," "could," "continue," "estimate," "expect," "evaluate," "forecast," "guidance," "intend," "likely," "may," "might," "objective," "ongoing," "outlook," "plan," "potential," "predict," "probable," "project," "seek," "should," "target," "view," "will," or "would," or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words.

These statements reflect the Company's reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company's ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company's ability to achieve positive cash flows; the Company's efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company's ability to capture market share; the Company's estimates of its potential addressable market and demand for its products and technologies; the Company's ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company's ability to continue as a going concern; the Company's ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company's products will become mandatory under the National Electrical Code (NEC), code or otherwise code mandatory in any jurisdiction, or that any of the Company's current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company's ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company's actual operating results; the potential impact of unstable market and economic conditions on the Company's business, financial condition, and stock price; and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q.

There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.

Copyright 2026 GlobeNewswire, Inc.